Pituitary Complications of Checkpoint Inhibitor Use.
Endocrinology
; 165(9)2024 Jul 26.
Article
em En
| MEDLINE
| ID: mdl-39001874
ABSTRACT
Immune checkpoint inhibitors have revolutionized cancer therapy but are associated with a risk of endocrine immune-related adverse events, including pituitary complications. Autoimmune hypophysitis, traditionally a rare diagnosis, has become a more frequently encountered clinical entity with the emergence of antitumor immunotherapy. This mini-review aims to consolidate current knowledge, encompassing the epidemiology, pathophysiology, clinical presentation, diagnosis, and management of pituitary complications of immune checkpoint inhibitor use.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Inibidores de Checkpoint Imunológico
Limite:
Humans
Idioma:
En
Revista:
Endocrinology
Ano de publicação:
2024
Tipo de documento:
Article
País de afiliação:
Estados Unidos